Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

PROPEL: a randomized trial of mericitabine plus peginterferon alpha-2a/ribavirin therapy in treatment-naïve HCV genotype 1/4 patients.

Wedemeyer H, Jensen D, Herring R Jr, Ferenci P, Ma MM, Zeuzem S, Rodriguez-Torres M, Bzowej N, Pockros P, Vierling J, Ipe D, Munson ML, Chen YC, Najera I, Thommes J; PROPEL Investigators..

Hepatology. 2013 Aug;58(2):524-37. doi: 10.1002/hep.26274. Epub 2013 Jun 26.

PMID:
23348636
2.

[Prophylaxis, diagnosis and therapy of hepatitis B virus infection - the German guideline].

Cornberg M, Protzer U, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Sarrazin C, Dollinger MM, Schirmacher P, Dathe K, Kopp IB, Zeuzem S, Gerlich WH, Manns MP; AWMF..

Z Gastroenterol. 2011 Jul;49(7):871-930. doi: 10.1055/s-0031-1273462. Epub 2011 Jul 11. German. No abstract available.

PMID:
21748700
3.

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Nelson DR, Benhamou Y, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Flisiak R, Rasenack JW, Kryczka W, Lee CM, Bain VG, Pianko S, Patel K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-2/3 Study Team..

Gastroenterology. 2010 Oct;139(4):1267-76. doi: 10.1053/j.gastro.2010.06.062. Epub 2010 Jul 1.

4.

Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a.

Marcellin P, Bonino F, Lau GK, Farci P, Yurdaydin C, Piratvisuth T, Jin R, Gurel S, Lu ZM, Wu J, Popescu M, Hadziyannis S; Peginterferon alfa-2a in HBeAg-negative Chronic Hepatitis B Study Group..

Gastroenterology. 2009 Jun;136(7):2169-2179.e1-4. doi: 10.1053/j.gastro.2009.03.006. Epub 2009 Mar 19.

PMID:
19303414
5.

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

Kamal SM, Ismail A, Graham CS, He Q, Rasenack JW, Peters T, Tawil AA, Fehr JJ, Khalifa Kel S, Madwar MM, Koziel MJ.

Hepatology. 2004 Jun;39(6):1721-31.

PMID:
15185314
6.

Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis.

Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ.

J Infect Dis. 2004 Apr 1;189(7):1140-50. Epub 2004 Mar 12.

PMID:
15031780
7.

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

Kamal SM, Fehr J, Roesler B, Peters T, Rasenack JW.

Gastroenterology. 2002 Oct;123(4):1070-83.

PMID:
12360469
8.

Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni.

Kamal SM, Bianchi L, Al Tawil A, Koziel M, El Sayed Khalifa K, Peter T, Rasenack JW.

J Infect Dis. 2001 Oct 15;184(8):972-82. Epub 2001 Sep 13.

PMID:
11574911
9.

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

Kamal SM, Rasenack JW, Bianchi L, Al Tawil A, El Sayed Khalifa K, Peter T, Mansour H, Ezzat W, Koziel M.

Gastroenterology. 2001 Sep;121(3):646-56.

PMID:
11522749
10.

Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni.

Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW.

Liver. 2000 Jul;20(4):281-9.

PMID:
10959806
11.

[Hepatitis C--standard therapy].

Rasenack JW.

Praxis (Bern 1994). 2000 Jun 15;89(24):1049-55. Review. German.

PMID:
10902461
12.

[Hepatitis B virus mutants--clinical significance].

Blum HE, Moradpour D, vøn Weizsäcker F, Wieland S, Peters T, Rasenack JW.

Z Gastroenterol. 1997 May;35(5):347-55. Review. German.

PMID:
9265394
13.

Immunosuppressive therapy and hepatitis C virus infection: the clinical course of liver disease.

Grotz WH, Peters TH, Schlayer HJ, Kirste G, Berthold H, Felten H, Schollmeyer PJ, Rasenack JW.

J Mol Med (Berl). 1996 Jul;74(7):407-12.

PMID:
8841953
14.

Hepatitis B virus infection without immunological markers after open-heart surgery.

Rasenack JW, Schlayer HJ, Hettler F, Peters T, Preisler-Adams S, Gerok W.

Lancet. 1995 Feb 11;345(8946):355-7.

PMID:
7845117

Supplemental Content

Loading ...
Support Center